Now, for the first time, researchers at Washington University in St. Louis have shown that brain plaques in apparently healthy individuals are associated with increased risk of diagnosis with Alzheimer's disease years later.
In two studies published this month in Archives of Neurology, scientists report that volunteers with brain plaques were more likely to have declining scores on annual cognitive tests, to show signs of shrinkage in a key brain area affected by Alzheimer's and to eventually be diagnosed with the disease.
"We don't have enough data yet to definitively say that people who scan positive for these brain plaques have presymptomatic Alzheimer's disease, but something is clearly going on that does not bode well for the health of their aging brains," says John C. Morris, the Harvey A. and Dorismae Hacker Friedman Distinguished Professor of Neurology and director of Washington University's Alzheimer's Disease Research Center (ADRC) and the Friedman Center for Aging.
Morris and others at the ADRC have previously found evidence that Alzheimer's disease harms the brain for years prior to typical diagnosis. They are pushing for earlier diagnosis as an essential step to successful treatment of Alzheimer's disease, but to do that they first have to seek earlier indicators of disease and then wait years to see if people with the indicators later develop symptomatic Alzheimer's.
According to Morris, the new papers are early and encouraging indicators that scientists are on track to pushing back the time at which diagnosis can be made.
"We only have a very small number of subjects to date, but what we're learning so far has been consistent with our predictions," he says.
The new studies were made possible by the development of an imaging agent, Pittsburgh Compound B (PiB), that lets scientists use positron emission tomography scans to detect amyloid plaques in living brains for the first time. Prior to PiB, clinicians could only verify the presence of brain plaques during autopsies. PiB scanning of ADRC research participants is directed by Mark Mintun, M.D., vice chair for research in radiology and professor of radiology at the University's Mallinckrodt Institute of Radiology.
Martha Storandt, Ph.D., professor of psychology and of neurology, led one of the studies, which compared a variety of factors in plaque-positive and plaque-negative subjects.
"One of the main things we wanted to know was whether people who scanned positive for brain plaques scored abnormally low on cognitive tests," she says. "They didn't, but when we looked at their annual testing records over a period of years, we saw that the scores of the plaque-positive group were declining, while those of the plaque-negative group were not."
Magnetic resonance imaging scans analyzed by Denise Head, Ph.D., assistant professor of psychology, revealed that brain areas hit hard by Alzheimer's disease, such as the parahippocampal gyrus, were smaller in subjects with plaques.
In a second study, led by Morris, researchers tracked a group of 159 volunteers, ages 51 to 88, who were scanned using PiB between 2004 and 2008. At the time of the scans, none of the participants showed signs of mental impairment. Twenty-three of the volunteers later developed mild impairment, and nine members of that group were diagnosed with Alzheimer's disease.
Those who stayed mentally healthy did not scan positive for plaques, but volunteers later diagnosed with problems did. Comparisons of the volumes of key brain structures revealed the same disparities seen in the other study: subjects who developed mental impairment had significant reductions in their parahippocampal gyrus and other structures affected by Alzheimer's.
According to Morris, a parallel effort at Washington University that analyzes cerebrospinal fluid to diagnose Alzheimer's earlier is also meeting with early success. That program is led by David Holtzman, M.D., the Andrew and Gretchen Jones Professor and chair of the Department of Neurology and Anne Fagan, Ph.D., research associate professor of neurology.
Morris speculates that earlier diagnosis and testing of new treatments may be possible within the next 10 years.
"There are risks inherent in Alzheimer's treatments, so we have to be careful that healthy people who are selected to receive these treatments to prevent dementia caused by Alzheimer's disease really do have presymptomatic disease," he says.
Morris JC, Roe CM, Grant EA, Head D, Storandt M, Goate AM, Fagan AM, Holtzman DM, Mintun MA. Pittsburgh Compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer's disease. Archives of Neurology, Dec. 14, 2009.
Storandt M, Mintun MA, Head D, Morris JC. Cognitive decline and brain volume loss are signatures of cerebral amyloid beta deposition identified with PiB. Archives of Neurology, Dec. 14, 2009.
Washington University School of Medicine's 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is one of the leading medical research, teaching and patient care institutions in the nation, currently ranked third in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.
Michael C. Purdy | EurekAlert!
New study points the way to therapy for rare cancer that targets the young
22.11.2017 | Rockefeller University
Penn study identifies new malaria parasites in wild bonobos
21.11.2017 | University of Pennsylvania School of Medicine
Heat from the friction of rocks caused by tidal forces could be the “engine” for the hydrothermal activity on Saturn's moon Enceladus. This presupposes that...
The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.
Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....
The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.
Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...
Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.
That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...
Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.
During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....
15.11.2017 | Event News
15.11.2017 | Event News
30.10.2017 | Event News
23.11.2017 | Information Technology
23.11.2017 | Physics and Astronomy
23.11.2017 | Life Sciences